-+ 0.00%
-+ 0.00%
-+ 0.00%

ACLARIS THERAPEUTICS - BOSAKITUG GENERALLY WELL TOLERATED IN ADMIRATION TRIAL

Reuters·11/16/2026 08:28:00

Please log in to view news